Skip to main content
EN → RO

Rectal cancer stages: what stage I, II, III and IV mean

by Dr. Cristi Blajut
stagingrectal cancerTNMprognosisstage

Rectal cancer stages

Rectal cancer staging is the process by which doctors determine how advanced the cancer is — how deep the tumor has invaded the rectal wall, whether it has spread to the lymph nodes, and whether there are distant metastases. This information is essential for choosing the optimal treatment and estimating prognosis.

The TNM staging system

Rectal cancer staging uses the TNM system (Tumor, Node, Metastasis), developed by the American Joint Committee on Cancer (AJCC):

  • T (Tumor) — how deep the tumor has invaded the rectal wall
  • N (Nodes) — whether there are cancer cells in the lymph nodes around the rectum
  • M (Metastasis) — whether the cancer has spread to distant organs (liver, lungs, peritoneum)

T classification (primary tumor)

  • T1 — tumor has invaded the submucosa (the layer beneath the mucosa)
  • T2 — tumor has invaded the muscularis propria (rectal muscle layer)
  • T3 — tumor has crossed the muscularis into the perirectal fatty tissue (mesorectum)
  • T4 — tumor invades adjacent organs (bladder, prostate, vagina) or peritoneum

N classification (lymph nodes)

  • N0 — no lymph node involvement
  • N1 — 1-3 lymph nodes with cancer cells
  • N2 — 4 or more lymph nodes involved

M classification (metastases)

  • M0 — no distant metastases
  • M1 — metastases present (most commonly in the liver or lungs)

Stage I — Localized rectal cancer

TNM: T1-T2, N0, M0

The tumor is limited to the rectal wall and has not reached the lymph nodes.

Treatment: Surgery alone (total mesorectal excision — TME). For very superficial T1 tumors, transanal local excision may be an option.

Prognosis: 5-year survival exceeds 90%. Most patients are completely cured.

Stage II — Locally advanced rectal cancer, no nodes

TNM: T3-T4, N0, M0

The tumor has crossed the rectal wall but the lymph nodes are clear.

Treatment: Usually neoadjuvant chemoradiotherapy (before surgery) followed by TME. Adjuvant chemotherapy may be recommended depending on risk factors.

Prognosis: 5-year survival is 70-85%, depending on the depth of invasion and response to neoadjuvant treatment.

Stage III — Rectal cancer with affected lymph nodes

TNM: Any T, N1-N2, M0

The cancer has spread to regional lymph nodes, regardless of the depth of tumor invasion.

Treatment: Total neoadjuvant chemotherapy (TNT) or chemoradiotherapy followed by TME and adjuvant chemotherapy. This is a treatable disease but requires an aggressive multimodal approach.

Prognosis: 5-year survival is 50-65%. Response to neoadjuvant treatment is an important prognostic factor — a pathological complete response (no cancer cells in the surgical specimen) indicates an excellent outcome.

Stage IV — Metastatic rectal cancer

TNM: Any T, Any N, M1

The cancer has spread to distant organs. The most common metastasis sites are the liver and lungs.

Treatment: Systemic chemotherapy is the main treatment. In selected cases, liver or lung metastases can be surgically resected, which significantly improves prognosis. Treatment is individualized and discussed within the multidisciplinary oncology board.

Prognosis: 5-year survival is 10-15% overall, but can reach 40-50% in patients whose metastases are completely resectable.

How the stage is determined

Staging is done through several investigations:

  1. Pelvic MRI — the most important examination for local tumor evaluation (T and N)
  2. Chest-abdomen-pelvis CT — to detect distant metastases (M)
  3. Endorectal ultrasound — useful for superficial tumors (T1-T2)
  4. Colonoscopy with biopsy — confirms the histological diagnosis
  5. Histopathological examination of the surgical specimen — final (pathological) staging is done after surgery

What restaging after treatment means

After neoadjuvant chemoradiotherapy, the tumor is reassessed by MRI (the ycTNM classification, where “y” indicates prior treatment). Response to treatment can be:

  • Complete response — tumor is no longer visible (opens the door to the Watch & Wait strategy)
  • Partial response — tumor has shrunk
  • Stable disease — no significant change

Why staging matters for the patient

The stage of rectal cancer determines:

  • What treatment you will receive — surgery alone, chemoradiotherapy + surgery, or chemotherapy alone
  • The order of treatments — whether treatment starts with chemotherapy or surgery
  • Overall prognosis — chances of cure and risk of recurrence
  • The monitoring plan — frequency of follow-up after treatment

Don’t hesitate to ask your oncologist about the exact stage of your disease and how it affects your treatment plan.

This article is for informational purposes only and does not replace medical consultation. Staging and treatment plan should be discussed with your multidisciplinary medical team.